Skip Nav Destination
Issues
1 April 2008
-
Cover Image
Cover Image
293T cells transfected with MUC1 and pEGFP-actin (green) were stimulated with ICAM-1-positive NIH3T3 transfectants and Z-stack confocal images were acquired. Every 10 minutes, the actin cytoskeleton (green) was 3-dimentionally reconstructed and the cell body was manually contoured (yellow line) at each plane in the Z-series. This allowed for calculation of the ratio of actin voxel intensity within the protrusions compared with that in the whole cell providing an accurate numerical representation of the cytoskeletal dynamics. For details see the article by Shen and colleagues on page 555. - PDF Icon PDF LinkTable of Contents
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
2007 G.H.A. Clowes Memorial Lecture
Angiogenesis, Metastasis, and the Cellular Microenvironment
Cancer Genes and Genomics
Monochromosome Transfer and Microarray Analysis Identify a Critical Tumor-Suppressive Region Mapping to Chromosome 13q14 and THSD1 in Esophageal Carcinoma
Josephine M.Y. Ko; Pui Ling Chan; Wing Lung Yau; Ho Kin Chan; King Chi Chan; Zhuo You Yu; Fung Mei Kwong; Lance D. Miller; Edison T. Liu; Li Chun Yang; Paulisally H.Y. Lo; Eric J. Stanbridge; Johnny C.O. Tang; Gopesh Srivastava; Sai Wah Tsao; Simon Law; Maria L. Lung
Cell Cycle, Cell Death, and Senescence
Localization of Fas/CD95 into the Lipid Rafts on Down-Modulation of the Phosphatidylinositol 3-Kinase Signaling Pathway
Marie Bénéteau; Mathieu Pizon; Benjamin Chaigne-Delalande; Sophie Daburon; Patrick Moreau; Francesca De Giorgi; François Ichas; Amélie Rebillard; Marie-Thérèse Dimanche-Boitrel; Jean-Luc Taupin; Jean-François Moreau; Patrick Legembre
DNA Damage and Cellular Stress Responses
Signaling and Regulation
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.